Davide Rinaldi @Karnikh: "𝟐𝟎𝟐𝟒 𝐊𝐚𝐫𝐧𝐢𝐤𝐡 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐑𝐞𝐬𝐮𝐦𝐞 This is..."

United Kingdom

𝟐𝟎𝟐𝟒 𝐊𝐚𝐫𝐧𝐢𝐤𝐡 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐑𝐞𝐬𝐮𝐦𝐞 This is intended as a resume for all my copiers first, and then for my followers who may be considering starting a copy. It could also be of interest to anyone visiting my page, helping them better understand my goals and strategy. 𝕆𝕧𝕖𝕣𝕧𝕚𝕖𝕨 2024 marked a milestone year in my eToro investment journey, as I not only achieved a significant portfolio return of +𝟓𝟏.𝟒𝟑%, but also outperformed my personal target of +20% for the year. Additionally, I surpassed traditional benchmarks - for the fourth time in five years - with the $SPX500 delivering approximately +25% and the $NSDQ100 achieving +27% during the same period. My disciplined approach to market opportunities and strategic asset allocation played a pivotal role in these results. Furthermore, these achievements earned me recognition as the 𝟱𝘁𝗵 𝗯𝗲𝘀𝘁 𝗣𝗼𝗽𝘂𝗹𝗮𝗿 𝗜𝗻𝘃𝗲𝘀𝘁𝗼𝗿 with a ʀɪꜱᴋ ꜱᴄᴏʀᴇ ᴏꜰ 𝟦 ᴏʀ ʙᴇʟᴏᴡ on EToro for 2024, ranking 𝟱𝘁𝗵 𝗼𝘂𝘁 𝗼𝗳 𝟳𝟲𝟱 Popular Investors in this category. 𝕂𝕖𝕪 𝕄𝕖𝕥𝕣𝕚𝕔𝕤 • 2024 Portfolio Return: +𝟧𝟣.𝟦𝟥% • 2-Year Cumulative Return: +𝟣𝟥𝟤.𝟪𝟨% • 5-Year Cumulative Return: +𝟦𝟦𝟦.𝟢𝟦% 𝕋𝕠𝕡 ℙ𝕖𝕣𝕗𝕠𝕣𝕞𝕚𝕟𝕘 𝕀𝕟𝕧𝕖𝕤𝕥𝕞𝕖𝕟𝕥𝕤 My portfolio’s success in 2024 was driven by outstanding performances across multiple sectors, with several investments delivering year-on-year (YoY) growth of 85% or more: • Nvidia ($NVDA): +184% • Barclays ($BARC.L): +92% • NatWest Group ($NWG.L): +85% • Cryptocurrencies: o Bitcoin ($BTC): +125% o Ethereum ($ETH): +120% o Stellar ($XLM): +140% o Ripple ($XRP): +155% o Tron ($TRX): +90% • Magnite ($MGNI): +87% • Spotify ($SPOT): +90% • Taiwan Semiconductor Manufacturing Company ($TSM): +95% These investments highlighted the strength of the technology sector, the continued growth of cryptocurrencies, and selective opportunities in financial stocks and media companies. 𝕃𝕖𝕒𝕣𝕟𝕚𝕟𝕘 𝕄𝕠𝕞𝕖𝕟𝕥𝕤 Despite strong overall performance, I faced challenges in navigating volatility within certain speculative sectors, particularly in early-stage energy startups. Additionally, I addressed missteps in pharmaceutical investments initiated during the lockdown period. These experiences taught me the value of accepting mistakes as part of growth rather than dwelling on them, reinforcing my commitment to learning and evolving as an investor. 𝕊𝕥𝕣𝕒𝕥𝕖𝕘𝕚𝕔 ℍ𝕚𝕘𝕙𝕝𝕚𝕘𝕙𝕥𝕤 • 𝘿𝙞𝙫𝙚𝙧𝙨𝙞𝙛𝙞𝙘𝙖𝙩𝙞𝙤𝙣: Successfully balanced exposure across sectors such as technology, finance, media, and digital assets to manage risk and capitalize on growth opportunities. Additionally, increased exposure to the REIT and banking sectors in response to lower interest rates, positioning the portfolio for future growth. • 𝙍𝙞𝙨𝙠 𝙈𝙖𝙣𝙖𝙜𝙚𝙢𝙚𝙣𝙩: Maintained a Risk Score of 4, aligning with my investment style and tolerance. While I am not actively seeking to lower it, I will continue to ensure it does not increase. • 𝘼𝙙𝙖𝙥𝙩𝙞𝙫𝙚 𝙎𝙩𝙧𝙖𝙩𝙚𝙜𝙞𝙚𝙨: Leveraged insights from market trends, including the surge in AI-driven stocks and renewed interest in decentralized finance (DeFi), to make timely investment decisions. • 𝘿𝙞𝙫𝙞𝙙𝙚𝙣𝙙 𝙔𝙞𝙚𝙡𝙙 𝙂𝙧𝙤𝙬𝙩𝙝: Increased dividend yield from 0.2% to 0.92%, enhancing income generation potential while maintaining a balanced risk profile. • 𝘾𝙤𝙣𝙨𝙤𝙡𝙞𝙙𝙖𝙩𝙞𝙤𝙣 𝙤𝙛 𝙃𝙞𝙜𝙝-𝙋𝙚𝙧𝙛𝙤𝙧𝙢𝙞𝙣𝙜 𝙋𝙤𝙨𝙞𝙩𝙞𝙤𝙣𝙨: Focused on consolidating current high-performing positions with a positive outlook for the future, reinforcing the long-term stability and potential of the portfolio. 𝔾𝕠𝕒𝕝𝕤 𝕗𝕠𝕣 𝟚𝟘𝟚𝟝 1. 𝘔𝘢𝘪𝘯𝘵𝘢𝘪𝘯 𝘎𝘳𝘰𝘸𝘵𝘩: Target a 15% annual return and continue to outperform market benchmarks. 2. 𝘗𝘳𝘰𝘧𝘦𝘴𝘴𝘪𝘰𝘯𝘢𝘭 𝘋𝘦𝘷𝘦𝘭𝘰𝘱𝘮𝘦𝘯𝘵: Pass the 𝘾𝙄𝙎𝙄 𝙇𝙚𝙫𝙚𝙡 𝟯 𝙞𝙣 𝙒𝙚𝙖𝙡𝙩𝙝 𝙈𝙖𝙣𝙖𝙜𝙚𝙢𝙚𝙣𝙩 and deepen my market knowledge. 3. 𝘚𝘶𝘴𝘵𝘢𝘪𝘯 𝘗𝘰𝘳𝘵𝘧𝘰𝘭𝘪𝘰 𝘓𝘪𝘲𝘶𝘪𝘥𝘪𝘵𝘺: Preserve 10-15% portfolio liquidity to seize emerging opportunities without requiring external cash infusions. 4. 𝘔𝘢𝘪𝘯𝘵𝘢𝘪𝘯 𝘙𝘪𝘴𝘬 𝘚𝘤𝘰𝘳𝘦: I am quite satisfied with the Risk 4 score as it reflects my inclination. I won’t go above and beyond to lower it further while I will endeavor not to increase it.

Not investment advice. The author may have financial interests in the mentioned instruments.

2 Mentioned

SPX500

SPX500 Index (Non Expiry)

NSDQ100

NASDAQ100 Index (Non Expiry)

Strictly Necessary Cookies

Performance Cookies

Functional Cookies

Targeting Cookies